LOS ANGELES CAPITAL MANAGEMENT LLC
Position in BMY — Bristol Myers Squibb Co
CIK 1177206
LOS ANGELES, CA
Position in BMY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$258,191,234
+$25,418,397 QoQ
Shares Held
4,257,069
-1.4% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 58.45893031097217.ToString("F0")%
Shared 0.ToString("F0")%
None 41.54106968902783.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $1,172,096,642 across 10 Drug Manufacturers - General names. BMY ranks #3 (22.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
454,512 | $418,046,502 | |
| 2 | ABBV |
AbbVie Inc.
|
1,260,942 | $274,242,275 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
4,257,069 | $258,191,234 | |
| 4 | JNJ |
Johnson & Johnson
|
369,494 | $90,319,113 | |
| 5 | AMGN |
Amgen Inc
|
187,621 | $66,014,448 | |
| 6 | PFE |
Pfizer Inc
|
1,112,386 | $31,235,798 | |
| 7 | MRK |
Merck & Co., Inc.
|
131,751 | $15,848,327 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
73,460 | $10,238,120 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $258,191,234 | 4,257,069 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $232,772,837 | 4,315,403 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $145,119,126 | 3,217,719 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $45,762,895 | 988,613 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $146,449,066 | 2,401,198 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $129,085,587 | 2,282,277 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $186,452,592 | 3,603,645 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $67,987,641 | 1,637,073 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $98,225,985 | 1,811,285 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $98,168,806 | 1,913,249 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $89,200,631 | 1,536,882 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $97,343,922 | 1,522,188 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $153,746,353 | 2,218,242 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $171,707,523 | 2,386,484 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $158,677,429 | 2,232,064 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $125,146,252 | 1,625,276 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $71,920,747 | 984,811 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $57,590,949 | 923,672 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $38,351,923 | 648,165 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $50,978,180 | 762,918 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $53,583,544 | 848,781 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $53,097,680 | 856,000 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $50,712,029 | 841,135 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $81,614,106 | 1,387,995 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $76,442,003 | 1,371,403 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||